111 Capital’s Pfizer PFE Stock Holding History

111 Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.71M	Buy	+153,909	New	+$4.03M	0.64%	28
2026 Q1	–	Sell	-21,114	Closed	-$526K	–	423
2025 Q4	$526K	Sell	21,114 -31,364	-60%	-$791K	0.11%	154
2025 Q3	$1.34M	Buy	52,478 +12,242	+30%	+$302K	0.25%	76
2025 Q2	$975K	Sell	40,236 -28,807	-42%	-$672K	0.17%	140
2025 Q1	$1.75M	Buy	69,043 +49,857	+260%	+$1.3M	0.34%	59
2024 Q4	$509K	Buy	+19,186	New	+$520K	0.11%	203

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

111 Capital's PFE Position: Q2 2026 in Review

111 Capital opened a new position in Pfizer (PFE) in Q2 2026: 153,909 shares worth $3.71M. The stake represents 0.64% of the portfolio and ranks #28 among its holdings. This is a return to the name: 111 Capital previously reported a position in PFE as recently as Q4 2025.

111 Capital first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

111 Capital held 153,909 shares of Pfizer worth $3.71M as of Q2 2026.
Pfizer was a new 111 Capital position in Q2 2026.
Pfizer made up 0.64% of 111 Capital's portfolio in Q2 2026, its #28 holding.
111 Capital first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.